₹280.60
+₹13.35 (+5.00%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹644 Cr
P/E
82.77
ROE
11.54%
ROCE
10.63%
About Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals is engaged in the manufacturing of pharmaceutical formulations for more than 3 decades.
Founded
1995
CEO
Ravichandran Chitra
Employees
406
HQ
Chennai, Tamil Nadu
About Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals is engaged in the manufacturing of pharmaceutical formulations for more than 3 decades.
Founded:1995
CEO:Ravichandran Chitra
Employees:406
HQ:Chennai, Tamil Nadu
Finished Products
1Revenue from Operations
₹150.94Cr2Export Sales
₹72.98Cr3Domestic Sales
₹72.03Cr4Other Operating Revenue
₹1.53Cr5Analytical Income
₹0.84CrRaw Materials
1Raw Material Consumed
₹153.50Cr2Purchase of stock in Trade
₹12.57CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹291
52W Low
₹95
Volume8.65K
Avg VolumeN/A
Beta0.27
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
82.77x
Valuation
P/B Ratio
6.70x
Valuation
EPS
₹3.29
Valuation
Dividend Yield
0.00%
Valuation
ROE
11.54%
Profitability
ROCE
10.63%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and trading of pharmaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
63.8%
International
36.2%
INDIA63.8%
ASIA21.8%
UK12.1%
AFRICA2.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.39x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-3.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.